BASF is reportedly preparing a renewed takeover bid for Evonik Industries, with financial sources suggesting a price range of €26-€28 per share, valuing the deal at €12-€13 billion. This potential acquisition, if confirmed, would significantly impact both companies and the specialty chemicals sector.
BASF is reportedly gearing up for another attempt to acquire Evonik Industries, with a new bid expected to be between €26 and €28 per share, a significant increase from its previous €24 offer. This potential move signals BASF's strong strategic interest in expanding its specialty chemicals portfolio, which could lead to substantial synergies and market consolidation. For Evonik shareholders, particularly the RAG-Stiftung, this represents a significant opportunity for a premium payout, while BASF investors might face concerns over the acquisition cost and potential integration challenges. Short-term, Evonik's stock is likely to see upward pressure on speculation, while BASF could experience some downward pressure due to the potential cost. Long-term, the success of the integration and realization of synergies will dictate the ultimate impact on BASF.